Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
Clinical trial NCT06663176 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06663176
- Sponsor
- Thirty Respiratory Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2028-02-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.